Skip to main content

Institutional filer profile

RA Capital Nexus Fund II L.P. Insider Trades

RA Capital Nexus Fund II L.P. has reported 2 open-market purchases on SEC Form 4 and is a net buyer of $95,347,991 across 2 companies. The most recent open-market transaction was reported on Nov 13, 2026. Source: SEC Form 4 filings.

Latest reported as Corporate insider of PepGen Inc. (PEPG).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
2
Reported companies
2
Net open-market value
$95,347,991
Latest transaction
Nov 13, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 13, 2026PepGen Inc. (PEPG)Corporate insiderOpen Market Purchase8,625,000$5.00$43,125,000
May 6, 2026Hemab Therapeutics Holdings, Inc. (COAG)Corporate insiderOpen Market Purchase2,840,429$18.39$52,222,991

Common questions

RA Capital Nexus Fund II L.P. insider trading FAQ

Is RA Capital Nexus Fund II L.P. buying or selling stock?
Across all SEC Form 4 open-market filings on record, RA Capital Nexus Fund II L.P. is a net buyer of $95,347,991, with 2 open-market purchases reported. The latest transaction was reported on Nov 13, 2026.
Which companies does RA Capital Nexus Fund II L.P. report insider trades for?
RA Capital Nexus Fund II L.P. has reported open-market trades in PepGen Inc. (PEPG), Hemab Therapeutics Holdings, Inc. (COAG). The latest SEC-reported relationship is Corporate insider of PepGen Inc. (PEPG).
Where does RA Capital Nexus Fund II L.P.'s insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under filer CIK 1825376, and refreshes this page daily.